$CTIC Company News Insider filings one way to
Post# of 74549
Posted On: 06/25/2014 1:22:14 PM
$CTIC Company News
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com
Insider Trading Alert - MWE, CPT And CTIC Traded By Insiders 10:16 a.m. June 9, 2014 - TheStreet.com
Name change for Cell Therapeutics 7:12 a.m. May 30, 2014 - Seeking Alpha
Thirteen Analyst Stocks Under $10 With Big Upside Calls 8:23 a.m. May 24, 2014 - 247WallSt.com
Why Cell Therapeutics (CTIC) Stock Is Spiking Today 12:27 p.m. May 22, 2014 - TheStreet.com
Interesting CTIC Put And Call Options For July 19th 10:51 a.m. May 20, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Cell Therapeutics: Enticing To All, Convincing To None 9:10 a.m. May 7, 2014 - Seeking Alpha
Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript 10:52 p.m. April 29, 2014 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:10 p.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape 9:21 a.m. April 29, 2014 - Zacks.com
Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 9:21 a.m. April 10, 2014 - Zacks.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. March 28, 2014 - Zacks.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month 10:39 a.m. March 24, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ... 10:12 a.m. March 24, 2014 - GuruFocus.com
Is It Too Late to Buy the Rally in Small Caps? 1:00 a.m. March 7, 2014 - InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:21 p.m. March 4, 2014 - Seeking Alpha
10-K: CELL THERAPEUTICS INC 6:32 p.m. March 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment 5:49 p.m. March 4, 2014 - Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation 10:47 a.m. Feb. 27, 2014 - Seeking Alpha
TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer 6:18 p.m. Jan. 31, 2014 - Seeking Alpha
Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom 6:00 a.m. June 13, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Initiates Randomized Phase 2 Trial Evaluating Tosedostat plus Cytarabine for Older Patients with AML or High-Risk MDS 1:30 a.m. June 12, 2014 - PR Newswire - PRF
Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp. 1:30 a.m. May 30, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Cell Therapeutics, Inc. Regarding Possible Breaches of Fiduciary Duty 12:52 p.m. May 29, 2014 - PR Newswire - PRF
CollabRx's Mobile App Simplifies Cancer Treatment Options 10:46 a.m. May 29, 2014 - ACCESSWIRE
Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 1:30 a.m. May 29, 2014 - PR Newswire - PRF
Top Gainers on the Move -- Research on Aeropostale, FirstEnergy, Cell Therapeutics, and Dyax 5:00 a.m. May 28, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Cell Therapeutics Reports First Quarter 2014 Financial Results 4:01 p.m. April 29, 2014 - PR Newswire - PRF
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma 1:30 a.m. April 29, 2014 - PR Newswire - PRF
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014 1:30 a.m. April 22, 2014 - PR Newswire - PRF
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics 8:00 a.m. March 18, 2014 - PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx 8:54 a.m. March 14, 2014 - PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference 2:30 a.m. March 5, 2014 - PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:00 p.m. March 4, 2014 - PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts 2:30 a.m. March 3, 2014 - PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 2:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 2:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 10:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com
Insider Trading Alert - MWE, CPT And CTIC Traded By Insiders 10:16 a.m. June 9, 2014 - TheStreet.com
Name change for Cell Therapeutics 7:12 a.m. May 30, 2014 - Seeking Alpha
Thirteen Analyst Stocks Under $10 With Big Upside Calls 8:23 a.m. May 24, 2014 - 247WallSt.com
Why Cell Therapeutics (CTIC) Stock Is Spiking Today 12:27 p.m. May 22, 2014 - TheStreet.com
Interesting CTIC Put And Call Options For July 19th 10:51 a.m. May 20, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Cell Therapeutics: Enticing To All, Convincing To None 9:10 a.m. May 7, 2014 - Seeking Alpha
Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript 10:52 p.m. April 29, 2014 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:10 p.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape 9:21 a.m. April 29, 2014 - Zacks.com
Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 9:21 a.m. April 10, 2014 - Zacks.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. March 28, 2014 - Zacks.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month 10:39 a.m. March 24, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ... 10:12 a.m. March 24, 2014 - GuruFocus.com
Is It Too Late to Buy the Rally in Small Caps? 1:00 a.m. March 7, 2014 - InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:21 p.m. March 4, 2014 - Seeking Alpha
10-K: CELL THERAPEUTICS INC 6:32 p.m. March 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment 5:49 p.m. March 4, 2014 - Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation 10:47 a.m. Feb. 27, 2014 - Seeking Alpha
TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer 6:18 p.m. Jan. 31, 2014 - Seeking Alpha
Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom 6:00 a.m. June 13, 2014 - PR Newswire - PRF
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Initiates Randomized Phase 2 Trial Evaluating Tosedostat plus Cytarabine for Older Patients with AML or High-Risk MDS 1:30 a.m. June 12, 2014 - PR Newswire - PRF
Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp. 1:30 a.m. May 30, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Cell Therapeutics, Inc. Regarding Possible Breaches of Fiduciary Duty 12:52 p.m. May 29, 2014 - PR Newswire - PRF
CollabRx's Mobile App Simplifies Cancer Treatment Options 10:46 a.m. May 29, 2014 - ACCESSWIRE
Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 1:30 a.m. May 29, 2014 - PR Newswire - PRF
Top Gainers on the Move -- Research on Aeropostale, FirstEnergy, Cell Therapeutics, and Dyax 5:00 a.m. May 28, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Cell Therapeutics Reports First Quarter 2014 Financial Results 4:01 p.m. April 29, 2014 - PR Newswire - PRF
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma 1:30 a.m. April 29, 2014 - PR Newswire - PRF
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014 1:30 a.m. April 22, 2014 - PR Newswire - PRF
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics 8:00 a.m. March 18, 2014 - PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx 8:54 a.m. March 14, 2014 - PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference 2:30 a.m. March 5, 2014 - PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:00 p.m. March 4, 2014 - PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts 2:30 a.m. March 3, 2014 - PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 2:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 2:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 10:17 a.m. Feb. 24, 2014 - ACCESSWIRE
(0)
(0)